LICCI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 519
EU - Europa 247
AS - Asia 88
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 856
Nazione #
US - Stati Uniti d'America 518
UA - Ucraina 70
TR - Turchia 60
IT - Italia 37
IE - Irlanda 36
SE - Svezia 34
DE - Germania 28
DK - Danimarca 27
FI - Finlandia 15
KR - Corea 14
SG - Singapore 10
CN - Cina 4
CA - Canada 1
CL - Cile 1
EU - Europa 1
Totale 856
Città #
Chandler 87
Jacksonville 70
Fairfield 58
Dublin 36
Wilmington 29
Cambridge 28
Ashburn 25
Woodbridge 24
Houston 20
Seattle 19
Boardman 18
New York 15
Lawrence 14
Princeton 14
San Mateo 14
Turin 13
Des Moines 7
Ann Arbor 4
Beijing 4
Izmir 4
Norwalk 3
San Diego 3
Helsinki 1
Pesaro 1
Toronto 1
Totale 512
Nome #
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 74
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 70
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 68
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 67
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 67
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 65
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 64
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. 60
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 59
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 58
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci. 57
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 57
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 51
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 50
Totale 867
Categoria #
all - tutte 3.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.872


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 0 4
2019/202084 0 0 14 0 14 0 14 0 14 0 1 27
2020/2021227 18 23 30 3 25 19 18 25 18 21 18 9
2021/202298 14 15 0 1 0 13 3 4 5 20 2 21
2022/2023234 14 37 14 18 15 22 1 14 60 1 32 6
2023/202477 21 1 3 18 16 17 1 0 0 0 0 0
Totale 867